Mirae Asset Global Etfs Holdings Ltd. Axogen, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 24,449 shares of AXGN stock, worth $443,993. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,449
Previous 25,185
2.92%
Holding current value
$443,993
Previous $465,000
43.01%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXGN
# of Institutions
169Shares Held
40.2MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$82.3 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$49.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$45.6 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$35.1 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $768M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...